2002, Número S1
<< Anterior Siguiente >>
Gac Med Mex 2002; 138 (S1)
Terapia génica para Hemofilia
Scott-Manno C
Idioma: Español
Referencias bibliográficas: 4
Paginas: 7-9
Archivo PDF: 29.36 Kb.
FRAGMENTO
No tiene resumen
REFERENCIAS (EN ESTE ARTÍCULO)
Herzog RW, Yang E, Couto L, et al. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nature Med 1999;5:56.
Kay M, Manno C, Ragni M, et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nature Genet 2000;24:257.
Roth DA, Tawa NE, O’Brien J, et al. Nonviral gene transfer of the gene encoding blood coagulation factor VIII in patients with severe hemophilia A. New Eng J Med 2001;344(23)1735.
Wang L, Nicholas T, Read M, et al. Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver. Molec Ther 2000;1:154.